Fareed Melhem is Senior Vice President in charge of Acorn AI Labs. Acorn AI Labs brings together data, technology, and expertise from Medidata and Partners to tackle the toughest problems in life sciences. A core focus of the Labs are the applications of data and advanced analytics to improve the design, planning, and execution of clinical trials. Prior to Medidata, he was an Associate Partner at McKinsey & Company where he led work with Biopharma, CROs, and Technology players in the R&D space. He co-led McKinsey’s Center for Analytics and Real World Evidence, advising clients on the application of advanced analytics across the product lifecycle. Fareed has written on the impact that data and analytics can have in driving in R&D and speaks regularly at conferences on the topic. Fareed holds an MBA from the Darden School of Business, University of Virginia and a BA in Economics and Math from Columbia University.
New approaches are being adopted to overcome the challenges associated with matching and enrolling patients to the most appropriate clinical trial. Identifying opportunities for patients requires both an understanding of the patients’ molecular profile and other key clinical attributes to ensure enrollment data. In this session, we will learn about innovative and novel approaches and technologies that address clinical trial enrollment challenges.